Botox helps post-traumatic headaches

August 4, 2014

Botox is FDA-approved only for chronic migraine headaches, however, it is being used “off-label” for other types of headaches as well. We find that frequent episodic migraines, cluster headaches, numular, and cervicogenic (neck-related) headaches improve with Botox. In our practice, post-traumatic headaches also seem to respond to Botox.

A report by neurologists from Stony Brook University describes five patients suffering from post-traumatic headaches, who responded to Botox. These patients sustained a traumatic brain injury and had suffered from post-traumatic headaches for years, despite trials of various prophylactic medications. After treatment with Botox, all of their five patients had greater than 50% improvement of their disability as measured by the MIDAS (MIgraine Disability Assessment Scale) questionnaire.

This is not a surprising observation because in many patients with a traumatic brain injury headaches have migraine features, suggesting similar underlying mechanisms. People with a family history of migraines who sustain a head injury seem to be more likely to develop post-traumatic headaches than those without such family history, which also suggests a link with migraines. Some patients with post-traumatic headaches and especially those with overt whiplash injury (almost all head injuries, to a varying degree, involve a whiplash neck injury) may respond to Botox because Botox relaxes tight muscles. We no longer think that this is the reason Botox helps migraines because there is evidence that in migraines Botox works by blocking sensory nerve endings rather than by relaxing muscles.

Because of the cost, insurance companies are often unwilling to pay for Botox to treat anything but chronic migraines. However, headaches that begin after a head injury and are accompanied by some migraine features can be correctly classified as post-traumatic chronic migraines, thus avoiding difficulties with the insurance companies.

Written by
Alexander Mauskop, MD
Continue reading
June 24, 2026
Fast Walkers Have Better Brain Health into their 80s
Taken together, the super mover data strengthen a simple, clinically useful message: how our oldest patients walk tells us a great deal about how their brains are aging. Fast, confident gait in the ninth decade is not just reassuring from a mobility standpoint; it signals cognitive resilience built on decades of better vascular health, regular physical activity, and supportive environments. For headache and neurology patients, this research offers one more reason to invest in walking, strength, balance, sleep, mood, and lifestyle change: protecting gait speed into late life may be one of the most practical ways to protect thinking and memory as well.
Read article
June 21, 2026
Research
Childhood Stress Rewrites the Body's Metabolism
Two new papers—one in Science and one in Biological Psychiatry—offer a more biologically grounded way to think about the long-term impact of early life stress. Rather than acting only at the psychological level, early adversity appears to leave lasting marks on both the epigenome and mitochondrial function. These findings suggest that early experience may help shape core aspects of cellular energy metabolism, a pathway already central to how we understand migraine.
Read article
June 17, 2026
Research
A New Controlled Trial Suggests Even a Short Behavioral Treatment Can BeEffective for Chronic Pain
A new randomized controlled trial in PAIN found that just six 30-minute CBT sessions for chronic musculoskeletal pain significantly reduced pain interference and improved sleep and physical quality of life, with benefits sustained at follow-up. The findings suggest that brief, scalable behavioral treatments could be integrated into routine primary care and headache practice to improve function without requiring long-term psychotherapy.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe